Pharmaceuticals
Shark Bites: Positioning for a Positive Catalyst in Aurinia Pharmaceuticals
AUPH has two very large market opportunities for its voclosporin drug.
Strength in Regeneron Stock May Not Last Long
The charts of REGN could use more than media coverage.
Does 'Aggressive' Bristol-Myers Have the Right Prescription for Investors?
BMY's announced acquisition of MyoKardia for $13B comes less than a year after its purchase of Celgene.
The Investment Angle of Covid-19
Stocks of companies that have Covid-19 vaccine candidates have boomed while those in the treatment space have not.
Seattle Genetics Hits New Highs and a Strategy Adjustment Is Needed
The charts and indicators of SGEN are looking healthy.
2 Dinged Biotech Stocks That Could Reward Investors in the Months Ahead
Shares of Heron Therapeutics and Myovant Sciences have taken hits but both companies still show promise.
Immatics Is a Bit Boy Who Cried Wolf
This is the type of chart that will grab the attention of momentum traders.
Abbott Labs Stock Could Still Slip Lower
Let's review the charts and indicators.
Sanofi Could Trade Sideways for the Weeks Ahead
I would consider SNY a hold at this point in time.
With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?
I see no reason to flee this name, therefore, I am not.